The Cost-Effectiveness of Periodic Safety Update Reports (PSURS) for Biologicals in Europe

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.953
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of Periodic Safety Update Reports in the Safety Management of Biopharmaceuticals

European Journal of Clinical Pharmacology
MedicinePharmacology
2012English

Biologicals and Biosimilars: Safety Issues in Europe

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

Preparation of a Periodic Safety Update Report

Safety and Risk of Pharmacotherapy
2018English

Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union

JAMA - Journal of the American Medical Association
Medicine
2008English

PUK12 Cost-Effectiveness of Immunosuppressive Regimens in Renal Transplant Recipients in Germany: A Model Update

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Getting the Cost Right in Cost-Effectiveness Analyses

American Journal of Psychiatry
PsychiatryMental Health
1997English

Systematic Review: Treatment Pattern and Clinical Effectiveness and Safety of Pharmaceutical Therapies for Crohn’s Disease in Europe

Clinical and Experimental Gastroenterology
Gastroenterology
2016English

The Cost-Effectiveness of Biopharmaceuticals

mAbs
AllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy